Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.

Neurology

Kang UJ, Nakamura K, Zhuang X. Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology. 2022 Aug 09; 99(6):258-259.

2022
https://researcherprofiles.org/profile/417420258
35940895

Kang UJ, Nakamura K, Zhuang X